YAGNG Jie,TAN Yunxia,WANG Ping,et al.Effect of Anmeidan on Serum Levels of BDNF, GFAP, and Irisin in Patients with Chronic Insomnia[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(16):170-177.
YAGNG Jie,TAN Yunxia,WANG Ping,et al.Effect of Anmeidan on Serum Levels of BDNF, GFAP, and Irisin in Patients with Chronic Insomnia[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(16):170-177. DOI: 10.13422/j.cnki.syfjx.20230291.
Effect of Anmeidan on Serum Levels of BDNF, GFAP, and Irisin in Patients with Chronic Insomnia
To explore the effect of Anmeidan on the sleep quality and serum levels of brain-derived neurotrophic factor (BDNF), glial fibrillary acidic protein (GFAP), and irisin in the patients with chronic insomnia.
Method
2
A multicenter, randomized, double-blind, placebo-controlled clinical study was carried out, including 480 patients with chronic insomnia (deficiency syndrome) in Wuhan (Hubei), Guangzhou (Guangdong), and Lanzhou (Gansu). They were randomized into an observation group and a control group at a ratio of 1∶1. The observation group was orally administered with Anmeidan granules at a dose of 11 g, 3 times per day, and the control group with Anmeidan simulant at a dose of 11 g, 3 times per day, Both groups of patients received sleep education after enrollment. After 4 weeks of medication, the Athens insomnia scale (AIS) scores, Spiegel scale scores, and serum levels of BDNF, GFAP, and irisin were compared between the two groups as well as between before and after treatment.
Result
2
A total of 480 adult patients with chronic insomnia were enrolled in this study, with 64 patients falled off. Finally, the 415 patients were included in the analysis, including 213 patients in the observation group and 202 patients in the control group. There was no difference in age or sex between the two groups of patients. Compared with before treatment, the treatment in both groups decreased the AIS and Spiegel scores (
P
<
0.01). After treatment, the observation group had lower AIS and Spiegel scores than the control group (
P
<
0.01). The treatment in the observation group slightly lowered the level of BDNF, elevated the level of irisin (
P
<
0.05), and lowered the level of GFAP (
P
<
0.05) in the serum. After treatment, the observation group showed higher level of irisin (
P
<
0.05) and lower levels of BDNF and GFAP in the serum than the control group.
Conclusion
2
Anmeidan may improve the sleep quality of patients with chronic insomnia by elevating the irisin level and lowering the GFAP level in the serum.
MASON G M,LOKHANDWALA S,RIGGINS T,et al.Sleep and human cognitive development[J].Sleep Med Rev,2021,57:101472.
MACDONALD K J,COTE K A.Contributions of post-learning REM and NREM sleep to memory retrieval[J].Sleep Med Rev,2021,59:101453.
KIM S M,ZHANG S,PARK J,et al.REM sleep deprivation impairs learning and memory by decreasing brain O-GlcNAc cycling in mouse[J].Neurotherapeutics,2021,18(4):2504-2517.
IRWIN M R,VITIELLO M V.Implications of sleep disturbance and inflammation for Alzheimer's disease dementia[J].Lancet Neurol,2019,18(3):296-306.
PACE-SCHOTT E F,GERMAIN A,MILAD M R.Sleep and REM sleep disturbance in the pathophysiology of PTSD: The role of extinction memory[J].Biol Mood Anxiety Disord,2015,5:3.
KUSZTOR A,RAUD L,JUEL B E,et al.Sleep deprivation differentially affects subcomponents of cognitive control[J].Sleep,2019,doi: 10.1093/sleep/zsz016http://dx.doi.org/10.1093/sleep/zsz016.
ZHANG J,ZHANG Z,HUANG S,et al.Acupuncture for cancer-related insomnia: A systematic review and Meta-analysis[J].Phytomedicine,2022,102:154160.
YIN X,LI W,LIANG T,et al.Effect of Electroacupuncture on insomnia in patients with depression: A randomized clinical trial[J].JAMA Netw Open,2022,5(7):e2220563.
ZHANG Y,LONG Y,YU S,et al.Natural volatile oils derived from herbal medicines: A promising therapy way for treating depressive disorder[J].Pharmacol Res,2021,164:105376.
TANG Y,WANG H,NIE K,et al.Traditional herbal formula Jiao-tai-wan improves chronic restrain stress-induced depression-like behaviors in mice[J].Biomed Pharmacother,2022,153:113284.
POSTUMA R B,IRANZO A,HU M,et al.Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: A multicentre study[J].Brain,2019,142(3):744-759.
IRWIN M R,VITIELLO M V.Implications of sleep disturbance and inflammation for Alzheimer's disease dementia[J].Lancet Neurol,2019,18(3):296-306.
SEXTON C E,SYKARA K,KARAGEORGIOU E,et al.Connections between insomnia and cognitive aging[J].Neurosci Bull,2020,36(1):77-84.
Anmeidan Regulates Hepatic Neurotransmitters and Circadian Rhythm in Rat Model of Insomnia via OX1R/PLCβ-1/PKCα/ERK1/2 Signaling Pathway
Protective Effects of Anmeidan on Cell Structure Against Neuronal Damage in Hippocampal CA1 Region of Sleep-deprived Rats
Anmeidan Improves Learning and Memory Ability of Sleep-deprived Rats by Regulating Astrocyte Activity
Anmeidan Modulates Circadian Rhythm of Spontaneous Activity and Influences Clock Proteins in Sleep-deprived Rats
Effect of Anmeidan in Improving Learning and Memory Levels of Sleep Deprived Rats Through Mitochondrial Mediated Hippocampal Neuronal Apoptosis
Related Author
XU Bo
WANG Ping
XIA Jing
XIE Guangjing
YE Zijing
QIN Qinghua
CHENG Jing
Guang-jing XIE
Related Institution
Engineering Research Center of Chinese Medicine Protection Technology and New Product Development, Ministry of Education, Hubei University of Chinese Medicine
Hubei Shizhen Laboratory
Hubei Provincial Hospital of Traditional Chinese Medicine
Institute of Geriatrics,Hubei University of Chinese Medicine
School of Basic Medicine, Hubei University of Traditional Chinese Medicine